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Abstract: The focus of  the present review of  literature 
is keratoconus, a progressive thinning of  the cornea. Be-
cause keratoconus usually induces irregular astigmatism, 
the most affected patients experience a decreased visual 
acuity that limits the correction using ophthalmic lenses. 
The CLEK (Collaborative Longitudinal Evaluation 
of  Keratoconus) is a study carried out in several centers 
with the aim of  describing the evolution and associations 
between the visual and physiological manifestations of  
keratoconus. Since the treatment of  keratoconus varies 
according to its severity, this paper proposes a summary 
of  the results of  the CLEK and a review of  the thera-
peutic options. 
Sommaire: La présente revue de littérature traite du 
kératocône, un amincissement progressif  de la cornée. 
Le kératocône induit habituellement de l’astigmatisme 
irrégulier de sorte que les patients les plus affectés ont 
une acuité visuelle diminuée limitant ainsi la correction à 
l’aide de lentilles ophtalmiques. La CLEK (Collabora-
tive Longitudinal Evaluation of  Keratoconus) est une 
étude effectuée dans plusieurs centres dans le but de dé-
crire l’évolution et les associations entre les manifesta-
tions visuelles et physiologiques des kératocônes. Étant 
donné que le traitement du kératocône varie selon la sévé-
rité, le présent article propose un sommaire des résultats 
du CLEK et un survol des options thérapeutiques. 
INTRODUCTION
Keratoconus is the most common dystrophy 
inducing corneal ectasia. According to the Na-
tional Keratoconus Institute, the occurrence of  
this disease is one in 2,000. Keratoconus is char-
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acterized by a progressive thinning of  the corneal stro-
ma and corneal ectasia over several decades. This disease 
generally starts in a very productive period of  patients’ 
lives: the twenties. This usually bilateral non-infl amma-
tory process induces myopia and irregular astigmatism 
that limits correction with ophthalmic lenses. The treat-
ment for keratoconus varies according to severity of  the 
case. The CLEK (Collaborative Longitudinal Evalua-
tion of  Keratoconus) study was done in several centers 
over an eight-year period with the aim of  describing the 
evolution and associations between the visual symptoms 
and physiological signs of  keratoconus. Over a thousand 
patients were recruited in 15 different U.S. clinics. This 
article represents part of  the literature review done as 
part of  a master’s degree on the density of  keratocytes 
in contact lens wearers with or without keratoconus. A 
summary of  the CLEK results followed by an overview 
of  the therapeutic options available to patients with 
keratoconus unsatisfi ed with their condition will be pre-
sented.
Collaborative Longitudinal Evaluation of 
Keratoconus (CLEK)
The overall goals of  the CLEK involved characterizing 
the visual and corneal changes as well as the quality of  
life of  patients with keratoconus. The study also intend-
ed to describe the progression of  changes over time. 
To do so, patients were fi rst examined when recruited 
(1995-2006), then every year afterwards. During each 
patient’s visit, the CLEK clinicians evaluated the follow-
ing aspects: vision-related quality of  life, case history, 
time wearing contact lenses, visual acuity, corneal signs, 
corneal scarring, topography, treatment method, and the 
parameters of  their adjustment to gas-permeable lenses 
allowing apical clearance. Finally, the cornea and the 
lens/cornea relationship through fl uorescein were pho-
tographed. This accumulation of  data on case develop-
ment was covered in several different publications that 
are summarized in the following section.
Vision-related factors
The National Eye Institute visual function question-
naire (NEI-VFQ) was fi lled out at the annual follow-
up exam by 1,166 patients. This questionnaire contains 
51 different scales. A binocular visual acuity lower than 
6/12 is associated with a low quality of  life on all scales 
except those about general health and eye pain. Kerato-
metric measurements higher than 52 diopters (D.) are 
correlated with poor results on the scales pertaining to 
mental health (loss of  control and concern caused by vi-
sion), work (diffi culty in close-up vision tasks at work), 
automobile driving (diffi culty driving during the day and 
at night), dependency (need for others and necessity 
of  staying at home) and eye pain (pain and discomfort 
around the eyes).1, 2 According to another study, there 
is no association between the subjective reduction in 
comfort when wearing gas-permeable lenses and the in-
crease in the severity of  keratoconus measured by the 
steepest keratometric curve or by the fi rst contact lens 
allowing apical clearance.3  
In a multi-centre study of  this scope, it was important 
to ensure repeatability of  the observations and consis-
tency among the various centers. Moreover, in a sample 
frequently wearing contact lenses, like the patients with 
keratoconus, the feasibility of  assessing the contact lens 
adjustment based on apical clearance using a photo-
graph and direct observation by the clinician was pos-
sible and useful.4,5  The lens/cornea relationship at the 
corneal apex of  the gas-permeable contact lenses ob-
served in the presence of  fl uorescein was assessed and 
categorized into four qualitative divisions: signifi cant 
touch, touch, clearance and signifi cant clearance. The 
repeatability and validity between the evaluations of  this 
type done by the clinicians during visits and by the clini-
cians using photographs are excellent.6 The repeatabil-
ity of  the visual acuity measurements of  keratoconus 
is comparable to normal subjects.7 On the other hand, 
the repeatability of  refractions of  subjects with kera-
toconus is lower than normal subjects. Over-refraction 
with contact lenses in place increases repeatability, but 
it remains lower than over-refraction done with normal 
subjects.8 Only 36% of  subjective refractions of  sub-
jects with keratoconus yielded repeatable spherical mea-
surements at +/- 0.50 diopters (D.) compared to 90% 
for normal subjects.9 It is important to account for this 
clinical variation in refraction when choosing the cor-
rection to apply to keratoconic patients.
On the other hand, the repeatability of  the three to-
pography instruments used in axial and tangential mode 
in this study, the EyeSys Model II, the Dicon CT 200 
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and the Keratron Corneal Analyser, is also reduced in 
the presence of  a keratoconic irregular cornea.10  The 
repeatability of  the topographies of  keratoconic cor-
neas using the Tomey 1 (TMS-1) instrument is also low-
er than that of  normal subjects.11
General characteristics of the
CLEK study subjects
The longitudinal observation of  1,209 patients helped 
describe the frequency of  characteristics of  these pa-
tients. The average age at recruitment was 39.3 +/- 10.9 
years of  age with moderate to severe keratoconus. Nine-
ty-fi ve percent of  the patients had a keratometry of  at 
least 45 diopters (D.). Sixty-fi ve percent were bilateral 
wearers of  gas-permeable lenses and 73% of  all wearers 
found them comfortable despite apical touch in 88% of  
adjustments. The best corrected visual acuity in each eye 
was 6/12 or better in 78% of  cases. Fifty-three percent 
had corneal scarring in at least one eye. Corneal opaci-
fi cation is associated with corneal staining, number of  
years worn, the presence of  a Fleischer ring and steeper 
corneas.12 In the case history, 13.5% reported the pres-
ence of  keratoconus in their family and 53% a personal 
history of  atopy.13 The only difference between the men 
and women following statistical analysis was in the pres-
ence of  Vogt striae and monocular and binocular high-
contrast visual acuity. The women had fewer Vogt striae 
and had lower visual acuity. In general, women tend to 
report symptoms more easily.14 A reduction in high- or 
low-contrast visual acuity was seen in the presence of  
corneal scarring.12, 15 
Factors associated with the presence of cor-
neal scarring
The evaluation of  the presence of  corneal scarring by 
the clinicians matches the evaluation done by external 
observers using photographs. Taking photos helped en-
sure that all of  the study’s clinicians had the same evalu-
ation criteria.16 The risk of  having corneal scarring is 
positively associated with the following factors: degree 
of  corneal curvature, age, the presence of  corneal stain-
ing or a Fleischer ring, wearing lenses.17 In the latter 
case, contact lens wearers have twice the risk of  devel-
oping corneal scars. It is important to eliminate apical 
touch of  contact lenses to reduce the risk of  developing 
scars.18 Figures 1 and 2 show the topography and biomi-
croscopic aspect of  a cornea from a keratoconic patient 
with scarring.
The increase in the corneal curve is related to the pres-
ence of  Vogt striae, the Fleischer ring and corneal scar-
ring. These biomicroscopically visible signs are more 
common, namely about 60% of  eyes, in corneas with 
keratoconus that is considered severe.19 The asymmetry 
between the two eyes of  keratoconic patients in terms 
of  corneal curvature, visual acuity, ametropia and corne-
al scarring is statistically signifi cant when compared to 
that of  myopic subjects who wear contact lenses. There 
is also an association between unilateral eye rubbing and 
asymmetry; the rubbed eye being the eye with the great-
est curvature.20  Patients with a more severe form of  
keratoconus are also more asymmetric in this disease.21
Several studies have long observed in the corneal 
stroma the presence of  proteinases, enzymes that can 
denature the proteins making up the cornea. For mark-
ing one of  these types of  enzymes, esterases, the CLEK 
study adapted a technique of  transferring conjunctival 
cells onto a membrane using impression cytology. This 
technique is preferable to taking a biopsy over the entire 
conjunctival thickness. The specimens from keratocon-
ic subjects had higher levels of  esterases than those in 
ARTICLE
ARTICLE
Figure 1. Medmont topography of a steeped cornea with 
keratoconus
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the control group, suggesting the presence of  enzymes 
capable of  destroying the corneal tissue.22 
On the other hand, contrary to previous publications 
indicating the possibility that keratoconus is caused by 
collagen anomalies, keratoconus is not associated with 
an increased risk of  having a connective tissue disease.13 
Moreover, the CLEK study did not investigate the 
pathophysiology of  keratoconus. Increased knowledge 
of  the mechanisms inducing keratoconus is needed to 
better defi ne appropriate treatments based on severity.
Treatment
The fi rst therapeutic approach involves adjusting rigid 
contact lenses in order to correct the irregular surface 
of  the cornea and improve vision, when the patient’s vi-
sual acuity is no longer satisfactory using glasses. There 
are several types of  gas-permeable lenses specialized for 
adjusting keratoconic corneas. Describing these lenses 
is outside the scope of  this article. However, one new 
development in the fi eld deserves to be mentioned. It 
is now possible to manufacture customized soft contact 
lenses. The lenses take into account aberrations of  the 
eye and corneal topography to achieve optimal correc-
tion.23
If  the patient becomes intolerant to gas-permeable 
lenses or if  declining visual acuity is no longer suffi -
cient for meeting the patient’s visual needs, “piggyback” 
lenses are sometimes prescribed. This wearing method 
combines a soft carrier lens, applied directly onto the 
cornea, with a small gas-permeable lens that can move 
around on the soft lens. This latter lens is sometimes 
manufactured so as to facilitate centering of  the semi-
rigid lens. As such, the set combines the comfort of  soft 
lenses with the visual acuity brought about by gas-per-
meable lenses.
Most often after failure of  contact lenses, penetrat-
ing keratoplasty (PK) called full-thickness corneal trans-
plant is done. This procedure involves substituting the 
central portion of  the cornea of  a keratoconus patient 
with a healthy cornea from a deceased donor. The fre-
quency of  keratoconus and the waiting time varies de-
pending on the countries concerned. In Canada, a retro-
spective study over 10 years shows that keratoconus is 
the second indication for penetrating keratoplasty with 
10% of  cases following pseudophakic bullous keratopa-
thy.24 The waiting time in Quebec is at least two years. 
In Brazil, keratoconus comes after ulcers and pseu-
dophakic bullous keratopathy.25 In China, keratoconus 
is the fourth indication for PK26 just like in the United 
States.27 The average time elapsed between keratoconus 
diagnosis and the transplant is 8.5 years in England.28 
According to a study done in a London tertiary refer-
ence centre, 21.6% of  keratoconic patients will need a 
corneal transplant.29 The best visual acuity lower than 
6/12, astigmatism greater than 10 D., a corneal curva-
ture greater than 55 D., an age of  30 years or less and 
a diagnosis 5 years ago or less increase the chance of  
needing a corneal transplant.30 However, the signifi cant 
cost connected with penetrating keratoplasty and the ab-
errations caused by the resulting irregular astigmatism is 
motivating surgeons to consider this approach as a last 
resort. Other techniques are now developed to prevent 
or delay penetrating transplant.
One of  those techniques, more delicate to perform 
Figure 2. Corneal scarring in the same patient as Figure 1 Figure 3. Keratoconic cornea with Intacs intra-corneal rings
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but less likely to result in signifi cant astigmatism, in-
volving replacing only part of  the cornea, is lamellar 
keratoplasty. Microkeratome-assisted deep lamellar ker-
atoplasty involves creating a corneal lamella in the host 
cornea and introducing the donor stroma and then re-
placing the lamella. This technique enables keeping the 
host endothelium. Some suggest injecting an air bubble 
into the anterior chamber to minimize the risks of  per-
foration before the formation of  the lamella.31 In some 
studies, refractive surgery was done six months after the 
stromal transplant using an excimer laser to correct the 
patient’s ametropia. The laser treatment is performed 
using the photorefractive keratoplasty (PRK) or LASIK 
(Laser in situ keratomileusis) method, in other words 
by removing the lamella to expose the stroma to the 
laser.  The results seem promising, but follow-ups were 
only done over a period of  7 to 22 months. In a study 
on 9 eyes of  7 keratoconus subjects, corneal thickness 
went from 432.7 to 578 μm on average after surgery. 
The corrected visual acuity of  all patients improved 
by an average of  fi ve lines.32 Another study on 50 eyes 
of  50 patients measured a best-corrected visual acuity 
(BCVA) of  6/12 in 88% of  patients one year after this 
procedure.33 PRK or LASIK was not done in this lat-
ter study. It should be noted that the use of  refractive 
surgery techniques with incisions like LASIK is far from 
being unanimously approved among practitioners. In 
fact, these techniques are contra-indicated for patients 
with keratoconus, because they increase corneal insta-
bility. Other promising approaches discussed further on 
are currently being tested.
One experimental therapeutic approach involves 
colonizing a polymer with keratocytes to then hope to 
replace the cornea of  patients affected by the new bio-
compatible material.34 This latter technique has been 
used successfully on four different patients whose cor-
neas had completely opacifi ed.35 
One last surgical option involves inserting rings into 
the mid-periphery of  the corneal stroma of  patients 
whose corneas are free of  scarring. These half-moon-
shaped intra-corneal rings attempt to fl atten the ocular 
surface. This reversible technique36 is especially appli-
cable to patients with mild keratoconus who no longer 
tolerate contact lenses and have poor visual acuity with 
glasses. Based on topography, location and size of  the 
cone, surgeons implant one or two segments horizon-
tally in lower or higher position.37 The segments must 
be placed asymmetrically in relation to the centre of  the 
cornea for best results.38 Implantation in more advanced 
cases required adjustment of  a contact lens because the 
correction made by the intra-corneal rings was limited.39 
Two types of  rings are marketed: Intacs and Ferrara. 
Intra-corneal rings can correct between –1.00 D and 
–3.00 D and up to 1.00 D astigmatism. The results from 
several studies that used them have recently been pub-
lished.38, 40-45 This procedure can also be performed on 
patients with marginal pellucid degeneration.46 Over a 
12-month period, the spherical equivalent of  36 eyes 
went from–7.29 D to –4.80 D.47 Following insertion 
of  segments in patients with keratoconus waiting for 
a corneal implant, best-corrected visual acuity went on 
average from 20/50 to 20/32.37 This limited procedure 
only mitigates the visual problems of  keratoconic pa-
tients. Figure 3 shows a cornea with intra-corneal rings. 
Some surgeons perform photorefractive keratec-
tomies (PRKs) or therapeutic photo-keratectomies 
(TPKs) on keratoconus. Even though keratoconus is a 
contra-indication for incisive refractive surgery, a Rus-
sian team attempted to correct the myopia and astig-
matism of  subjects with keratoconus using an excimer 
laser treatment.48 Since keratoconus is an anomaly that 
starts in the anterior stroma and gradually progresses to 
the posterior stroma, the team claims to be able to halt 
the progression of  the cone in mild keratoconus cases 
with PRK. This highly controversial treatment report-
edly slows the progress in nearly 91% of  cases over a 
follow-up period of  3.5 years.48, 49 Another team from 
California performed the same procedure on keratoco-
nus subjects with similar results.50, 51 Long-term follow-
up on these patients will better assess the relevance and 
actual effectiveness of  this treatment, because the risk 
that treated keratoconus will progress further is present. 
While waiting, TPK can be used to remove apical opac-
ity causing intolerance to contact lenses without cor-
recting the ametropia.52
One new approach involves inserting an intra-ocular 
lens to correct myopia in subjects with stable keratoco-
nus. The residual astigmatism is corrected by making a 
relaxing incision parallel to the limbus53 or keratoplasty 
with intra-corneal rings.54  Toric intra-ocular lenses can 
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also be inserted into the anterior chamber.55 No large-
scale results are currently available for evaluating this 
technique.
With the aim of  slowing the progress of  keratoconus, 
it is possible to alter the cornea’s resistance to deforma-
tions. The cornea’s rigidity can be increased by modify-
ing the interweaving of  the collagen fi bres. The method 
used involves incising the epithelium at the center of  
the cornea to apply drops of  ribofl avin (vitamin B2). 
The cornea is then exposed to ultraviolet A (UVA) ra-
diation for a 30-minute period. This procedure was pre-
viously tested on rabbits to confi rm its safety.56 UVA 
radiation is toxic for the endothelium of  corneas that 
are thinner than 400 μm.57 Ribofl avin alone is not toxic 
for the endothelium.58 However, apoptosis of  kerato-
cytes is observed on an anterior depth of  50 μm.59 The 
fi rst study on humans involved 23 eyes of  22 different 
patients. The follow-up length varied between 3 months 
and 4 years. No treated keratoconus advanced. The ker-
atometry dropped by 2.01 D and ametropia by 1.14 D. 
in the case of  16 eyes. However, no improvement in 
visual acuity was observed.56 Further studies are needed 
to set the markers for this technique.
 Some teams have successfully inserted, using a virus 
or plasmids, new genes into the corneal keratocytes of  
rabbits or rats in vivo.60-64 Other carriers have success-
fully been used in vitro in humans.65, 66 For example, 
the effectiveness of  the transduction of  the gene im-
planted by cationic liposomes into human keratocytes 
is 40.5%.66 The hope for this treatment method lies in 
the possibility of  identifying the defective genes to then 
modify them.
Conclusion
The CLEK is an excellent descriptive study of  the 
changes in and characteristics of  keratoconus. However, 
this study has several weaknesses. Since this study was 
started in 1995, the contact lenses do not use current 
designs. Moreover, the study does not look at posterior 
keratoconus, since the topography instruments used 
could not analyse the posterior curvature of  the cornea. 
The characteristics described in this study help with bet-
ter assessing the chance of  progression and with guid-
ing treatment. The many treatment options clearly show 
the heterogeneity of  keratoconus. Keratoconus is the 
end result of  several different processes affecting the 
cornea the same way that several processes affect the 
optic nerve in glaucoma. A better understanding of  the 
pathophysiological mechanisms is needed for categoriz-
ing and defi ning the sub-groups affected by this disease 
in order to manage the development of  it and select the 
best treatment option. At present, treatment selection is 
based on case severity without considering the process 
causing the disease.
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